Earnings Feed
Start Free
Home/Filings/4/0001033408-09-000002
4//SEC Filing

MCNEILL JOHN A JR 4

Accession 0001033408-09-000002

CIK 0001003124other
View on SEC.govCompany Profile

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 5:32 PM ET

Size

25.5 KB

Accession

0001033408-09-000002

Insider Transaction Report

Form 4
Period: 2009-02-19
PHARMACEUTICAL PRODUCT DEVELOPMENT INCPPDI
MCNEILL JOHN A JR
Director
Transactions
  • Other

    Common Stock

    2009-02-19+100,000→ 365,485 total(indirect: By Partnership)
  • Exercise/Conversion

    Stock Options (to buy)

    2009-04-28−8,000→ 0 total
    Exercise: $6.25From: 1999-05-12Exp: 2009-05-11→ Common Stock (8,000 underlying)
  • Exercise/Conversion

    Common Stock

    2009-04-28$6.25/sh+16,000$100,000→ 59,713 total
  • Other

    Common Stock

    2009-02-19−100,000→ 2,623,571 total(indirect: By Trust)
  • Exercise/Conversion

    Stock Options (to buy)

    2009-04-28−8,000→ 0 total
    Exercise: $6.25From: 1999-05-12Exp: 2009-05-11→ Common Stock (8,000 underlying)
Holdings

  • Stock Options (to buy)

    Exercise: $12.81From: 2002-05-15Exp: 2012-05-14→ Common Stock (12,000 underlying)
    12,000

  • Stock Options (to buy)

    Exercise: $15.06From: 2004-05-19Exp: 2014-05-18→ Common Stock (16,000 underlying)
    16,000

  • Stock Options (to buy)

    Exercise: $23.79From: 2005-05-18Exp: 2015-05-17→ Common Stock (5,458 underlying)
    5,458

  • Stock Options (to buy)

    Exercise: $35.38From: 2006-05-17Exp: 2016-05-16→ Common Stock (3,973 underlying)
    3,973

  • Stock Options (to buy)

    Exercise: $4.50From: 2000-05-16Exp: 2010-05-15→ Common Stock (16,000 underlying)
    16,000

  • Stock Options (to buy)

    Exercise: $13.58From: 2003-05-14Exp: 2013-05-13→ Common Stock (16,000 underlying)
    16,000

  • Stock Options (to buy)

    Exercise: $33.82From: 2007-05-16Exp: 2017-05-15→ Common Stock (6,126 underlying)
    6,126

  • Stock Options (to buy)

    Exercise: $42.77From: 2008-05-21Exp: 2018-05-20→ Common Stock (6,265 underlying)
    6,265

  • Common Stock

    (indirect: By Trust)
    10,156

  • Common Stock

    (indirect: By LLC)
    1,195

  • Stock Options (to buy)

    Exercise: $15.82From: 2001-05-15Exp: 2011-05-14→ Common Stock (8,000 underlying)
    8,000

Documents

1 file

Issuer

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

CIK 0001003124

→
Entity typeother

Related Parties

1
  • filerCIK 0001033408

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 5:32 PM ET
Size
25.5 KB
View on SEC.gov